Ascendis Pharma ADR Unsponsored Brazilian Depositary Receipt Repr 0.0666 ADR earnings per share and revenue

A1SN34 earnings per share for the last quarter are -6.25 BRL whereas the estimation was -1.53 BRL which accounts for -309.57% surprise. Company revenue for the same period amounts to 1.34 B BRL despite the estimated figure of 1.33 B BRL. Estimated earnings per share for the next quarter are 0.56 BRL, and revenue is expected to reach 1.52 B BRL. Also watch annual changes over time to get a bigger picture of A1SN34 earnings per share and revenue dynamics.